Travere Therapeutics, Inc. (TVTX): Shares Outstanding
90.92M
As of 2025-12-31
94.17M
As of 2026-06-30
+12.2%
3-year compound annual growth
+11.7%
5-year compound annual growth
+9.6%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 90.92M | +4.0% | 2026-02-19, Balance as of period end |
| 2024-12-31 | 87.45M | +16.0% | 2026-02-19, Balance as of period end |
| 2023-12-31 | 75.37M | +17.2% | 2025-02-21, Balance as of period end |
| 2022-12-31 | 64.29M | +2.9% | 2024-02-20, Balance as of period end |
| 2021-12-31 | 62.49M | +19.6% | 2023-02-23, Balance as of period end |
| 2020-12-31 | 52.25M | +21.3% | 2022-02-24, Balance as of period end |
| 2019-12-31 | 43.09M | +4.1% | 2021-03-01, Balance as of period end |
| 2018-12-31 | 41.39M | +5.1% | 2020-02-24, Balance as of period end |
| 2017-12-31 | 39.37M | +3.9% | 2019-02-26, Balance as of period end |
| 2016-12-31 | 37.91M | +4.0% | 2018-07-06, Balance as of period end |
| 2015-12-31 | 36.47M | +40.0% | 2017-03-01, Balance as of period end |
| 2014-12-31 | 26.05M | +41.4% | 2016-02-26, Balance as of period end |
| 2013-12-31 | 18.42M | +105.7% | 2015-07-09, Balance as of period end |
| 2012-12-31 | 8.95M | +121.5% | 2015-07-09, Balance as of period end |
| 2011-12-31 | 4.04M | n/a | 2013-09-16, Balance as of period end |